Table 2.
Baseline characteristics of the study population.
| Descriptor | Total Sample (n = 20) |
|---|---|
| Mean (SD) | |
| Age (years) | 74.3 (11.7) |
| Height (cm) | 164.4 (7.4) |
| Weight (kg) | 82.5 (15.6) |
| BMI (kg/m2) | 30.7 (4.5) |
| Gender | N (%) |
| Female | 8 (40) |
| Male | 12 (60) |
| Ethnicity | |
| Australian | 14 (70) |
| Non-Australian | 6 (30) |
| Medication | |
| Combined Hypoglycaemic Treatment | 7 (35) |
| Biguanides | 11 (55) |
| DPP-4 Inhibitors | 1 (5) |
| Sulphonylureas | 1 (5) |
| Categories of Surgery | |
| Orthopaedic | 6 (30) |
| Gastrointestinal | 4 (20) |
| Cardiac | 9 (45) |
| Urogenital | 1 (5) |
| Weight Status | |
| Normal weight (BMI, 18.5–25 kg/m2) | 3 (15) |
| Overweight BMI, 25–30 kg/m2) | 5 (25) |
| Obese (BMI > 30 kg/m2) | 12 (60) |
BMI, body mass index; DPP4, dipepdidyl-peptidase-4.